Keya Medical showcased its advanced DeepVessel FFR technology at booth 114.
This innovative solution for deep-learning-based CT-FFR analysis drew significant interest and sparked engaging conversations with many of you.
We appreciate everyone who stopped by to learn more about how DeepVessel FFR can enhance diagnostic precision and patient care. Your enthusiasm and feedback are invaluable.
We invite you to reach out If you missed us at the show or want to continue the conversation. Contact Keya Medical for more information or to schedule a personalized demonstration. We look forward to further discussions and collaborations.
Thank you again for making SCCT2024 a success!
About DEEPVESSEL FFR
DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA). The software processes coronary CTA images semi-automatically, generates a three-dimensional model of the coronary artery tree, and estimates CT FFR values. DEEPVESSEL FFR is FDA-Cleared, CE-Marked, and NMPA-Cleared.
About Keya Medical
Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. Follow us on LinkedIn, Twitter, and Facebook.
Media Contact
contact@keyamedna.com